Slowly inactivating potassium conductance (ID): A potential target for stroke therapy

Stroke

Volumn 32, Issue 11, 2001, Pages 2624-2634

  Bains, Jaideep S ^a   Follwell, Matthew J ^a   Latchford, Kevin J ^a   Anderson, James W ^a   Ferguson, Alastair V ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Angiotensins; Excitotoxicity; N methyl D aspartate; Neuroprotection; Potassium channels; Rats; Stroke prevention; Stroke, experimental

Indexed keywords

4 AMINOPYRIDINE; ANGIOTENSIN; ANGIOTENSIN RECEPTOR; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; POTASSIUM CHANNEL; POTASSIUM ION; N METHYLASPARTIC ACID; NEUROPROTECTIVE AGENT; POTASSIUM CHANNEL BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; HISTOPATHOLOGY; HYPOTHALAMUS; IN VITRO STUDY; IN VIVO STUDY; MAGNOCELLULAR NUCLEUS; MALE; NERVE CELL MEMBRANE STEADY POTENTIAL; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PATCH CLAMP; POTASSIUM CONDUCTANCE; PRIORITY JOURNAL; RAT; REPOLARIZATION; SPONTANEOUSLY HYPERTENSIVE RAT; STROKE; THALAMUS MIDLINE NUCLEUS; ANIMAL; ANTERIOR HYPOTHALAMUS; CELL CULTURE; CELL DEATH; CEREBROVASCULAR ACCIDENT; CYTOLOGY; DRUG EFFECT; ELECTRIC CONDUCTIVITY; EXCITATORY POSTSYNAPTIC POTENTIAL; HUMAN; KINETICS; NERVE CELL; PHYSIOLOGY; POTASSIUM CHANNEL; RAT STRAIN;

4-AMINOPYRIDINE; ANGIOTENSIN II; ANIMAL; CELL DEATH; CELLS, CULTURED; CEREBROVASCULAR ACCIDENT; ELECTRIC CONDUCTIVITY; EXCITATORY POSTSYNAPTIC POTENTIALS; HUMAN; HYPOTHALAMUS; KINETICS; MALE; N-METHYLASPARTATE; NEURONS; NEUROPROTECTIVE AGENTS; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; RATS; RATS, INBRED SHR; RATS, SPRAGUE-DAWLEY; RECEPTORS, ANGIOTENSIN; SUPPORT, NON-U.S. GOV'T;

EID: 0035167701     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/hs1101.098332     Document Type: Article

References (53)

1. The toxic effect of sodium 1-glutamate on the inner layers of the retina
2. Brain lesions in an infant rhesus monkey treated with monosodium glutamate
3. Excitotoxicity and the NMDA receptor
4. Ionic dependence of glutamate neurotoxicity
5. Glutamate neurotoxicity and diseases of the nervous system
6. The role of glutamate neurotoxicity in hypoxicischemic neuronal death
7. Differential vulnerability of autonomic and somatic motor neurons to N-methyl-D-aspartate-induced excitotoxicity
8. Ibotenate-induced cell death in the hypothalamic paraventricular nucleus: Differential susceptibility of magnocellular and parvicellular neurons
9. Hyperpolarising after-potentials prevent long duration plateau depolarisations in rat paraventricular nucleus neurons
10. Central mammalian neurons normally resistant to glutamate toxicity are made sensitive by elevated extracellular Ca2+: Toxicity is blocked by the N-methyl-D-aspartate antagonist MK-801
11. Synaptic activity mediates death of hypoxic neurons
12. Ischemic cell death in brain neurons
13. Periinfarct depolarizations
14. Characterization of cortical depolarizations evoked in focal cerebral ischemia
15. Potassium-induced cortical spreading depressions during focal cerebral ischemia in rats: Contribution to lesion growth assessed by diffusion-weighted NMR and biochemical imaging
16. Electrophysiology of glutamate neurotoxicity in vitro: Induction of calcium-dependent extended neuronal depolarization
17. + current in hippocampal neurons
18. Dendritic calcium spike initiation and repolarization are controlled by distinct potassium channel subtypes in CA1 pyramidal neurons
19. Diversity and ubiquity of K channels
20. The organization of forebrain afferents to the paraventricular and supraoptic nuclei in the rat
21. A consideration of neural counting methods
22. Nitric oxide regulates NMDA-driven GABAergic inputs to type I neurons of the rat paraventricular nucleus
23. Dissociated adult rat subfornical organ neurons maintain membrane properties and angiotensin responsiveness for up to 6 days
24. D,L-(Tetrazol-5-yl) glycine: A novel and highly potent NMDA receptor agonist
25. Heteromeric NMDA receptors: Molecular and functional distinction of subtypes
26. Differential effects of BDNF, ADNF9, and TNFalpha on levels of NMDA receptor subunits, calcium homeostasis, and neuronal vulnerability to excitotoxicity
27. Calcium-mediated mechanisms of ischemic injury and protection
28. Ca2+ influx through glutamate receptor-associated channels in retina cells correlates with neuronal cell death
29. Voltage-gated currents distinguish parvocellular from magnocellular neurones in the rat hypothalamic paraventricular nucleus
30. Electrophysiological properties of neurones in the region of the paraventricular nucleus in slices of rat hypothalamus
31. Angiotensin II actions in paraventricular nucleus: Functional evidence for a neurotransmitter role in efferents originating in subfornical organ
32. Subfornical organ efferents to the paraventricular nucleus utilize angiotensin as a neurotransmitter
33. Angiotensin II responsiveness of rat paraventricular and subfornical organ neurons in vitro
34. Activation of N-methyl-D-aspartate receptors evokes calcium spikes in the dendrites of rat hypothalamic paraventricular nucleus neurons
35. Measurement of immunoreactive angiotensin II levels in microdissected brain nuclei from developing spontaneously hypertensive and Wistar Kyoto rats
36. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
37. Stroke prevention by losartan in stroke-prone spontaneously hypertensive rats
38. Angiotensin II receptor antagonist delays renal damage and stroke in salt-loaded Dahl salt-sensitive rats
39. Potassium channels: Molecular defects, diseases, and therapeutic opportunities
40. An MRI substudy of a double-blind, placebo-controlled, safety and efficacy trial of intravenous BMS-204352 in patients with acute stroke
41. Double-blind, placebo controlled, safety and efficacy trials of intravenous BMS-204352 in patients with acute stroke
42. Modulation of A-type potassium channels by a family of calcium sensors
43. Differential inhibition of glial K(+) currents by 4-AP
44. Enhanced fast synoptic transmission and a delayed depolarization induced by transient potassium current blockade in rat hippocampal slice as studied by optical recording
45. Physiology and pharmacology of epileptiform activity induced by 4-aminopyridine in rat hippocampal slices
46. Potassium currents modulation of calcium spike firing in dendrites of cerebellar Purkioje cells
47. K+ channel regulation of signal propagation in dendrites of hippocampal pyramidal neurons
48. Electrical and calcium signaling in dendrites of hippocampal pyramidal neurons
49. A by angiotensin II
50. Two pharmacologically and kinetically distinct transient potassium currents in cultured embryonic mouse hippocampal neurons
51. Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1,1.2,1.3,1.5, and 3.1, stably expressed in mammalian cell lines
52. Voltage-gated K+ channel beta subunits: Expression and distribution of Kv beta 1 and Kv beta 2 in adult rat brain
53. Modulation of a slowly inactivating potassium current, I(D), by metabotropic glutamate receptor activation in cultured hippocampal pyramidal neurons